ABSTRACT
COVID-19 is not finished yet because at past the SARS-CoV-2 virus has been discovered a much lofty infectivity than old covid viruses previously identified, effective treatments and vaccination are the top strategy to prevent the infection’s spread. Other viral diseases, such as severe acute respiratory syndrome and Middle East respiratory syndrome, pale in comparison, the COVID-19 fatality rate is lower. COVID19-related mortality has increased over the world as a result of the emergence of SARS-CoV-2 mutations that cause the disease in these following waves. In current scenario, the severity of SARS-CoV-2 infection is quite high, resulting in a massive increase in the total number of deaths worldwide. Researchers believe SARS-CoV-2 could develop into a seasonal illness, similar to influenza, and that it will continue to affect humans in the future. Currently, the only way to combat COVID-19 is to adopt preventive techniques such as sanitation and social segregation, mask use, and vaccinations. To handle this specific problem, different Indian government-publicprivate consortia devised various approaches (including the production of multiple vaccines), including expanding immunisations and sample testing every day. In this concentrated study, we looked at the threats faced and the success stories used to manage COVID-19.
